Edition:
United Kingdom

ConvaTec Group PLC (CTEC.L)

CTEC.L on London Stock Exchange

122.65GBp
18 Feb 2019
Change (% chg)

4.10 (+3.46%)
Prev Close
118.55
Open
120.15
Day's High
123.00
Day's Low
119.55
Volume
1,916,036
Avg. Vol
5,189,164
52-wk High
240.50
52-wk Low
113.25

Latest Key Developments (Source: Significant Developments)

ConvaTec Group Sees FY2019 Organic Revenue Growth To Be 1 Pct To 2.5 Pct
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - ConvaTec Group PLC ::FOURTH QUARTER AND ANNUAL RESULTS 2018.GROUP REPORTED FY REVENUE OF $1,832.1 MILLION, GREW 3.8% YEAR ON YEAR.GUIDANCE FOR FY2019: ORGANIC REVENUE GROWTH EXPECTED TO BE 1% TO 2.5%, ADJUSTED EBIT MARGIN 18% TO 20%.MEDIUM TO LONG TERM, TARGETING REVENUE GROWTH IN LINE WITH OR ABOVE MARKET AND ADJUSTED EBIT MARGIN EXPANSION.FY ADJUSTED EBIT OF $429.4 MILLION WAS DOWN 6.0% YEAR ON YEAR.CONVATEC GROUP SAYS "THESE ARE DISAPPOINTING RESULTS, IN LIGHT OF OUR REVENUE AND MARGIN GUIDANCE AT BEGINNING OF 2018".NOW IMPLEMENTING A REFRESHED EXECUTION MODEL TO SUPPORT STRATEGY AND DELIVER SUSTAINABLE AND PROFITABLE GROWTH.SAYS "IT IS CLEAR THAT SWIFT AND STRONG ACTION IS REQUIRED TO ADDRESS FAILURES".RECOGNISE THAT THERE REMAINS SIGNIFICANT UNCERTAINTY AROUND THE EVENTUAL BREXIT OUTCOME.DO NOT BELIEVE THAT BREXIT WILL GENERATE UNMANAGEABLE RISKS FOR OUR BUSINESS..ASSESSED POTENTIAL IMPACT OF BREXIT DELAYS ON SUPPLY CHAIN, PUT IN PLACE MITIGATION PLANS, REVIEWING INVENTORY, STOCK POSITIONING.  Full Article

Blackrock Inc Discloses 5.2 Pct Stake In Convatec Group
Friday, 19 Oct 2018 

Oct 19 (Reuters) - ConvaTec Group PLC ::BLACKROCK INC DISCLOSES 5.2 PERCENT STAKE IN CONVATEC GROUP PLC - FILING.  Full Article

Convatec Group HY Reported Revenue $921.3 Mln, up 10.8 Pct
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - ConvaTec Group PLC ::CONVATEC GROUP PLC SAYS HY GROUP REPORTED REVENUE OF $921.3 MILLION GREW 10.8 PERCENT YEAR ON YEAR.CONVATEC GROUP PLC SAYS GUIDANCE FOR FULL YEAR CONFIRMED WITH ORGANIC REVENUE GROWTH 2.5 PERCENT - 3.0 PERCENT AND ADJUSTED EBIT MARGIN 24 PERCENT - 25 PERCENT.CONVATEC GROUP PLC SAYS HY GROSS MARGIN 59.3 PERCENT VERSUS 60.3 PERCENT.  Full Article

Convatec Group Says Gets US FDA 510(K) Clearance For Aquacelt AG Advantage
Tuesday, 24 Jul 2018 

July 24 (Reuters) - ConvaTec Group PLC ::US FDA 510(K) CLEARANCE FOR AQUACELT AG ADVANTAGE.RECEIVES U.S. FDA 510(K) CLEARANCE FOR ITS MOST ADVANCED AND INNOVATIVE ANTIMICROBIAL DRESSING: AQUACEL ™ AG ADVANTAGE DRESSING.  Full Article

UBS Says Nordic Capital Sold 143.2 Mln Shares In Convatec
Thursday, 3 May 2018 

May 3 (Reuters) - UBS Ltd: :RESULT OF PLACING OF ORDINARY SHARES IN CONVATEC GROUP PLC.NORDIC CAPITAL IT SOLD 143.2 MILLION ORDINARY SHARES IN CONVATEC GROUP PLC.PLACING BY WAY OF AN ACCELERATED BOOKBUILD PROCESS AT A PRICE OF 220 PENCE PER ORDINARY SHARE, RAISING GROSS PROCEEDS OF £315 MILLION.CONVATEC WILL NOT RECEIVE ANY PROCEEDS FROM PLACING.UBS LIMITED ACTED AS SOLE BOOKRUNNER IN CONNECTION WITH PLACING.  Full Article

Convatec Group Q1 Group Revenue $458.2 Mln, Up 3.7 Pct
Wednesday, 2 May 2018 

May 2 (Reuters) - ConvaTec Group PLC ::Q1 GROUP REVENUE OF $458.2 MILLION GREW 3.7%.2018 FINANCIAL GUIDANCE RE-AFFIRMED: ORGANIC REVENUE GROWTH 2.5% TO 3.0%; ADJUSTED EBIT MARGIN 24% TO 25%.Q1 OSTOMY CARE REVENUE DECLINED 2.5%.Q1 ADVANCED WOUND CARE REVENUE GREW 2.2%.  Full Article

Convatec reports Q3 revenue of $445.5 mln, up 6.8 pct
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Convatec Group Plc ::IN Q3, GROUP REVENUE WAS $445.5 MILLION, REFLECTING 6.8 PCT REPORTED GROWTH ON SAME PERIOD IN 2016​.PERFORMANCE IN Q3 SEVERELY IMPACTED BY SUPPLY ISSUES IN BOTH ADVANCED WOUND AND OSTOMY CARE.‍GROUP NOW ANTICIPATE FULL YEAR ORGANIC REVENUE GROWTH WILL BE BETWEEN 1% AND 2%​.‍SUPPLY ISSUES ARE EXPECTED TO RESULT IN LOSS OF 40 BPS OF MARGIN BENEFIT ACHIEVED AS A RESULT OF MIP PROGRAMME IN FIRST HALF OF YEAR​.  Full Article

Photo

FTSE 100 squeezes out gains; ConvaTec drags midcaps

Britain's main stock index clung on to last session's advance, aided by earnings-driven gains in AstraZeneca and Micro Focus, while medical device maker ConvaTec single-handedly contributed to nearly one-third of the midcap index's dip.